Mirae Asset Global ETFs Holdings’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$56.4M Buy
224,280
+26,041
+13% +$5.6M 0.07% 257
2026
Q1
$42.8M Buy
198,239
+10,396
+6% +$2.31M 0.06% 284
2025
Q4
$42.9M Sell
187,843
-154,171
-45% -$35.1M 0.06% 279
2025
Q3
$79.1M Buy
342,014
+122,659
+56% +$25M 0.13% 166
2025
Q2
$40.7M Sell
219,355
-120,450
-35% -$22.4M 0.08% 246
2025
Q1
$71.2M Buy
339,805
+54,966
+19% +$10.7M 0.15% 147
2024
Q4
$50.6M Sell
284,839
-39,933
-12% -$7.34M 0.11% 206
2024
Q3
$64.1M Buy
324,772
+45,481
+16% +$8.49M 0.14% 150
2024
Q2
$47.9M Buy
+279,291
New +$46.3M 0.11% 181

Other funds holding ABBV

Mirae Asset Global ETFs Holdings's ABBV Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its AbbVie (ABBV) stake by 13% in Q2 2026, buying an estimated $5.6M and bringing the position to 224,280 shares worth $56.4M. The position accounts for 0.07% of the portfolio, ranked #257.

Mirae Asset Global ETFs Holdings first reported a position in ABBV in Q2 2024 and has held it in 9 quarters since. The position peaked at $79.1M in Q3 2025. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 224,280 shares of AbbVie worth $56.4M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 26,041 AbbVie shares in Q2 2026, an estimated $5.6M.
  • AbbVie made up 0.07% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #257 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in AbbVie in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's AbbVie position peaked at $79.1M in Q3 2025.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.